Literature DB >> 32812778

The Association Between Alcoholic Liver Disease and Alcohol Tax.

Sadaf Aslam1, Jacentha Buggs2, Samantha Melo3, Aizara Ermekbaeva4, Ebonie Rogers5, Robert Shaw1, Ambuj Kumar1, Nyingi Kemmer6.   

Abstract

BACKGROUND: The incidence of alcoholic liver disease (ALD) has increased, causing it to become a primary indication for liver transplantation in the United States. We hypothesized an association between alcohol taxation and prevalence of ALD.
METHODS: We conducted a retrospective study of united network for organ sharing (UNOS) waitlist additions for liver transplantation between January 2007 and December 2016. We also analyzed the average excise tax (2007-2016) for beer, wine, and spirits in listing states of liver transplant waitlist additions (LTWA).
RESULTS: There were 104 805 adult UNOS LTWA with assigned diagnoses, an annual increase from 22% to 28%. There were 24 316 LTWA with ALD diagnosis. The mean value for beer tax was significantly lower for ALD patients than for non-ALD patients across all age groups (P < .001). The analysis demonstrated significantly more ALD in waitlisted patients 35-54 years of age (30%), compared with 18-34 years (10%) and ≥55 years (20%), P < .001. The data confirmed significantly more ALD Medicaid patients in the 35-54 year age group (28%) compared with other age groups, P < .001. DISCUSSION: Our research demonstrated an association between lower beer tax and higher ALD prevalence across all age groups. We found a larger percentage of middle-aged (35-54 years) Medicaid patients listed with ALD. These findings raise the need for further investigation of a potential public health concern for an association between ALD and beer tax, especially for middle-aged patients of lower socioeconomic status.

Entities:  

Keywords:  alcohol consumption; alcohol tax; alcoholic liver disease

Year:  2020        PMID: 32812778     DOI: 10.1177/0003134820945223

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  3 in total

Review 1.  Covid-19 and alcohol associated liver disease.

Authors:  Sasha Deutsch-Link; Brenda Curtis; Ashwani K Singal
Journal:  Dig Liver Dis       Date:  2022-08-03       Impact factor: 5.165

2.  Seabuckthorn polysaccharide combined with astragalus polysaccharide ameliorate alcoholic fatty liver by regulating intestinal flora.

Authors:  Jiayue Liu; Lingzhou Kong; Mengting Shao; Changhai Sun; Changxu Li; Yanyan Wang; Xue Chai; Yuliang Wang; Yu Zhang; Xiaoliang Li; Hong Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

Review 3.  Epidemiology of Alcohol-Associated Liver Disease.

Authors:  Sen Han; Zhihong Yang; Ting Zhang; Jing Ma; Kristina Chandler; Suthat Liangpunsakul
Journal:  Clin Liver Dis       Date:  2021-05-26       Impact factor: 6.265

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.